Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
Divya Ail, Hugo Malki, Emilia A. Zin, et al.
The Application of Clinical Genetics (2023) Vol. Volume 16, pp. 111-130
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Nucleic acid-based drugs for patients with solid tumours
Sebastian G. Huayamares, David Loughrey, Hyejin Kim, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 407-427
Closed Access | Times Cited: 14
An adeno-associated virus variant enabling efficient ocular-directed gene delivery across species
Shuang Luo, Hao Jiang, Qingwei Li, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Breaking genetic shackles: The advance of base editing in genetic disorder treatment
Fang Xu, Caiyan Zheng, Weihui Xu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9
The AAV2.7m8 capsid packages a higher degree of heterogeneous vector genomes than AAV2
Mengtian Cui, Qin Su, Mitchell Yip, et al.
Gene Therapy (2024) Vol. 31, Iss. 9-10, pp. 489-498
Closed Access | Times Cited: 5
Drug product formulation and fill/finish manufacturing process considerations for AAV-based genomic medicines
Madhura Som, Benson Gikanga, Varna Kanapuram, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 7, pp. 1711-1725
Closed Access | Times Cited: 4
AAV-mediated gene therapy for sialidosis
Diantha van de Vlekkert, Huimin Hu, Jason A. Weesner, et al.
Molecular Therapy (2024) Vol. 32, Iss. 7, pp. 2094-2112
Open Access | Times Cited: 4
Combining Steric Exclusion with Anion Exchange – Development of a universal and scalable Adeno-Associated Virus Downstream Process
Frederik Meierrieks, João Maurício Rosário, Lena Rübeling, et al.
Journal of Chromatography A (2025) Vol. 1743, pp. 465674-465674
Open Access
Engineered virus-like particle-assembled VEGF-targeting Cas9 ribonucleoprotein treatment alleviates neovascularization in wet age-related macular degeneration
Jun Wu, Hyewon Jang, Hyunjong Kwak, et al.
Research Square (Research Square) (2025)
Closed Access
The clinical safety landscape for ocular AAV gene therapies: a systematic review and meta-analysis
Z. Liu, Haoliang Zhang, Huixun Jia, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 112265-112265
Open Access
The Opportunities and Challenges of Gene Therapy for Treatment of Inherited Forms of Vision and Hearing Loss
Emmanuel J. Simons, Ivana Trapani
Human Gene Therapy (2023) Vol. 34, Iss. 17-18, pp. 808-820
Closed Access | Times Cited: 10
Temporal insights into molecular and cellular responses during rAAV production in HEK293T cells
Alok Tanala Patra, Evan Tan, Yee Jiun Kok, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101278-101278
Open Access | Times Cited: 3
A Novel and Simplified Anion Exchange Flow‐Through Polishing Approach for the Separation of Full From Empty Adeno‐Associated Virus Capsids
Frederik Meierrieks, Alisa Weltken, Karl Pflanz, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 10
Open Access | Times Cited: 3
The Role of Artificial Intelligence and Machine Learning in Accelerating the Discovery and Development of Nanomedicine
Vivek Agrahari, Yahya E. Choonara, Mitra Mosharraf, et al.
Pharmaceutical Research (2024)
Closed Access | Times Cited: 2
Exploration of the Noncoding Genome for Human-Specific Therapeutic Targets—Recent Insights at Molecular and Cellular Level
Wolfgang Poller, Susmita Sahoo, Roger J. Hajjar, et al.
Cells (2023) Vol. 12, Iss. 22, pp. 2660-2660
Open Access | Times Cited: 6
Adeno-associated virus vectors for retinal gene therapy in basic research and clinical studies
Xue Xia, Xinzheng V. Guo
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 6
Characterization of anti-AAV2 neutralizing antibody levels in sheep prior to and following intravitreal AAV2.7m8 injection
Maya Ross, Kareen Sade, Alexey Obolensky, et al.
Gene Therapy (2024) Vol. 31, Iss. 11-12, pp. 580-586
Open Access | Times Cited: 1
Preclinical evaluation of NG101, a potential AAV gene therapy for wet age-related macular degeneration
J.H. Shim, Yeo Hyung Kim, J.G. Bak, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 4, pp. 101366-101366
Open Access | Times Cited: 1
Emerging strategies targeting genes and cells in glaucoma
Sonali Roy
Vision Research (2024) Vol. 227, pp. 108533-108533
Open Access | Times Cited: 1
Exploration of the Noncoding Genome for Human-Specific Therapeutic Targets – Recent Insights at Molecular and Cellular Level
Wolfgang Poller, Susmita Sahoo, Roger J. Hajjar, et al.
(2023)
Open Access | Times Cited: 2
Patient derived model of UBA5-associated encephalopathy identifies defects in neurodevelopment and highlights potential therapies
Helen Chen, Yong‐Dong Wang, Aidan W Blan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The significance of chemical transfection/transduction enhancers in promoting the viral vectors-assisted gene delivery approaches: A focus on potentials for inherited retinal diseases
Sajad Najafi, Azam Rahimpour, Hamid Ahmadieh, et al.
Electronic Journal of Biotechnology (2024)
Open Access
Infantile Nystagmus Syndrome—Associated Inherited Retinal Diseases: Perspectives from Gene Therapy Clinical Trials
Xiujie Gong, Richard W. Hertle
Life (2024) Vol. 14, Iss. 11, pp. 1356-1356
Open Access
Agarose hydrogel-mediated electroporation method for retinal tissue cultured at the air-liquid interface
Megan L. Stanchfield, Hannah H. Lee, Edward M. Levine
iScience (2024) Vol. 27, Iss. 12, pp. 111299-111299
Open Access
Evaluation of subretinally delivered Cas9 ribonucleoproteins in murine and porcine animal models highlights key considerations for therapeutic translation of genetic medicines
Spencer C. Wei, Aaron J. Cantor, Jack Walleshauser, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
mTOR Downregulation Promotes Anti-Inflammatory Responses via the CCL3-CCR5 Axis in Hypoxic Retinopathy
Tae Kwon Moon, Insug Kang, Kyoung Jin Lee, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 33, Iss. 1, pp. 101404-101404
Open Access
Page 1 - Next Page

Scroll to top